MENU
TLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Telix Pharmaceuticals (TLX) Ownership - Who owns Telix Pharmaceuticals?
Telix develops radiopharmaceuticals to manage cancer... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.41B
P/E Ratio
170.95
Total Cash
710.35M
Projected Growth
N/A
Total Debt
581.45M
Revenue
783.21M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.12
Total Debt/Equity
N/A
Revenue/Share
1.48 USD as % of share price
Fundamentals
TLX
Capitalization
5.41B
P/E Ratio
170.95
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
710M
Total Cash/Share
2.12
Total Debt
581M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.48%
Revenue
783M
ROE
N/A
Book Value
568M
P/B Ratio
14.56
Cash Flow
N/A
Earnings
0.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
2.78
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
92.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
5.21
Shares Held By Institutions
793K
Shares Outstanding - Current
335M
Total Liabilities
948M
Total Volume MTD
N/A
Value
-1
Gain YTD
4.481
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information